Dendreon Corporation Shares Halted Ahead of FDA Meeting

Published: Mar 29, 2007

SAN FRANCISCO (MarketWatch) -- Shares of Dendreon Corp. were halted before the start of trading Thursday, ahead of a Food and Drug Administration advisory committee meeting to evaluate Provenge, the company's experimental prostate-cancer drug.

>>> Discuss This Story

Back to news